{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:58:14Z","timestamp":1790780294828,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1097\/01.coc.0000145983.35929.2a","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T08:01:05Z","timestamp":1117180865000},"page":"270-276","source":"Crossref","is-referenced-by-count":30,"title":["Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately High to Highly Emetogenic Chemotherapy"],"prefix":"10.1097","volume":"28","author":[{"given":"Celeste","family":"Lindley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Ahinee","family":"Amamoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Shord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trin","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Yowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Laliberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Socinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199003223221205","article-title":"Comparison of the 5-hydroxytryptamine 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.","volume":"322","author":"Marty","year":"1990","journal-title":"N Engl J Med"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-113-11-834","article-title":"Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: a multicenter, randomized, double-blind cross-over study.","volume":"113","author":"DeMulder","year":"1990","journal-title":"Ann Intern Med"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0936-6555(05)80953-7","article-title":"Ondansetron (GR 38032) in the prophylaxis of acute and delayed cisplatin-induced emesis.","volume":"2","author":"Roila","year":"1990","journal-title":"Clin Oncol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1200\/JCO.1989.7.1.108","article-title":"Controlling delayed emesis: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.","volume":"7","author":"Kris","year":"1989","journal-title":"J Clin Oncol"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy induced nausea and emesis after modern antiemetics perception versus reality.","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0149-2918(96)80226-8","article-title":"Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.","volume":"18","author":"Crucitt","year":"1996","journal-title":"Clin Ther"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","article-title":"Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines.","volume":"17","author":"Gralla","year":"1999","journal-title":"J Clin Oncol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ajhp\/56.8.729","article-title":"ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery.","volume":"56","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1023\/A:1008471812316","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference.","volume":"9","year":"1998","journal-title":"Ann Oncol"},{"key":"R10-10-20210128","first-page":"57","article-title":"NCCN Antiemesis Practice Guidelines (NCCN Proceedings).","volume":"11","year":"1997","journal-title":"Oncology"},{"key":"R13-10-20210128","first-page":"1963","article-title":"A randomized double blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.","volume":"8","author":"Bonneierre","year":"1990","journal-title":"J Clin Oncol"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0277-5379(90)90227-K","article-title":"A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study.","volume":"26","author":"Kaasa","year":"1990","journal-title":"Eur J Cancer"},{"key":"R15-10-20210128","first-page":"1127","article-title":"Double-blind randomized trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide.","volume":"27","author":"Marscher","year":"1991","journal-title":"Eur J Cancer"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0140-6736(91)90554-3","article-title":"Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy.","volume":"338","author":"Jones","year":"1991","journal-title":"Lancet"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199501053320101","article-title":"Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.","volume":"332","year":"1995","journal-title":"N Engl J Med"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<64::AID-CNCR11>3.0.CO;2-#","article-title":"Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.","volume":"86","author":"Hickok","year":"1999","journal-title":"Cancer"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.1989.7.8.1142","article-title":"Incidence and duration of chemotherapy induced emesis in an outpatient oncology population.","volume":"7","author":"Lindley","year":"1989","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.coc.0000145983.35929.2a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:20:58Z","timestamp":1620937258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200506000-00010"}},"subtitle":["Comparison of Ondansetron, Prochlorperazine, and Dexamethasone"],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000145983.35929.2a","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}